In vitro effects of L-arginine and guanidino compounds on NTPDase1 and 5′-nucleotidase activities from rat brain synaptosomes

International Journal of Developmental Neuroscience

Volumn 21, Issue 2, 2003, Pages 75-82

  Balz, Daniela ^a   De Souza Wyse, Angela Terezinha ^b   Morsch, Vera Maria ^a   Da Silva, Adriane Cismoski ^a   Vieira, Vânia Lúcia ^a   Morsch, André Luís Bittencourt ^a   Schetinger, Maria Rosa Chitolina ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Homoarginine and argininic acid; L Arginine; N Acetylarginine; NTPDase1 and 5 nucleotidase

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; APYRASE; ARGININE; GUANIDINE DERIVATIVE; NUCLEOTIDASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN CORTEX; BRAIN DYSFUNCTION; CONTROLLED STUDY; DISORDERS OF AMINO ACID AND PROTEIN METABOLISM; ENZYME ACTIVITY; HYDROLYSIS; IN VITRO STUDY; MALE; NEUROTOXICITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SYNAPTOSOME;

EID: 0344406892     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0736-5748(02)00138-7     Document Type: Article

References (44)

1. Bonan C.D., Dias M.M., Battastini A.M.O., Dias R.D., Sarkis J.J.F. Inhibitory avoidance learning ectonucleotidases activities in hippocampal synaptosomes of adult rats. Neurochem. Res. 23:1998;979-984.
2. Bonan C.D., Roesler R., Pereira G.S., Battastini A.M.O., Izquierdo I., Sarkis J.J.F. Learning-specific decrease in synaptosomal ATP diphosphohydrolase activity from hippocampus and entorhinal cortex of adult rats. Brain Res. 854:2000;253-256.
3. Bon C.L., Garthwaite J. Nitric oxide-induced potentiation of CA1 hippocampal synaptic transmission during baseline stimulation is strictly frequency-dependent. Neuropharmacology. 40:2001;501-507.
4. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
5. Brusilow, S.W., Horwich, A., 2001. Urea cycle enzymes. In: Scriver, C.R., Beaudet, A.L., Sly, W.S., Valle, D. (Eds.), The Metabolic and Molecular Bases of Inherited Disease, Eighth ed. McGraw-Hill, New York, pp. 1909-1963.
6. Burnstock G., Williams M. P2 purinergic receptors: modulation of cell function and therapeutic potential. J. Pharmacol. Exp. Ther. 295:2000;862-869.
7. 2+-ATPase activity. Anal. Biochem. 157:1986;375-380.
8. Cunha R.A., Ribeiro J.A. ATP as presynaptic modulator. Life Sci. 68:2000;119-137.
9. De Deyn P.P., Marescau B., Lornoy W., Becaus I., Lowenthal A. Guanidino compounds in uraemic dialysed patients. Clin. Chim. Acta. 157:1986;143-150.
10. De Mendonça A., Sebastião A.M., Ribeiro J.A. Adenosine: does it have a neuroprotective role after all? Brain Res. Rev. 33:2000;258-274.
11. During M.J., Spencer D.D. Adenosine: a mediator of seizure arrest and postictal refractoriness. Ann. Neurol. 32:1992;618-624.
12. Gazziola C., Ferraro P., Moras M., Reichard P., Bianchi V. Cytosolic high K(m) 5′-nucleotidase and 5′(3′)-deoxyribonucleotidase in substrate cycles involved in nucleotide metabolism. J. Biol. Chem. 276:2001;6185-6190.
13. Guieu R., Dussol B., Halimi G., Bechis G., Sampieri F., Berland Y., Sampol J., Couraud F., Rochat H. Adenosine and the nervous system: pharmacological data and therapeutic perspectives. Pharmacology. 31:1998;553-561.
14. Handa M., Guidotti G. Purification and cloning of a soluble ATP-diphosphohydrolase (apyrase) from potato tubers (Solanum tuberosum). Biochem. Biophys. Res. Commun. 130:1996;139-145.
15. Heymann D., Reddington M., Kreutzberg G.W. Subcellular localization of 5′-nucleotidase in rat brain. J. Neurochem. 43:1984;971-978.
16. Hyrayasu, Y., Morimoto, K., Otsuki, S., Mori, A., 1994. Increase of guanidinoacetic acid and methylguanidine in the brain following amygdala kindling in rats. In: De Deyn, P.P., Marescau, B., Stalon, V., Qureshi, I.A. (Eds.), Guanidino Compounds in Biology and Medicine. John Libby & Company, London, pp. 419-424.
17. Kegel B., Braun N., Maliszewski C.R., Heine P., Zimmermann H. An ecto-ATPase and ecto-ATP diphosphohydrolase are expressed in the brain. Neuropharmacology. 36:1997;1189-1200.
18. Kirchner S.M., Bonan C.D., Battastini A.M.O., Sarkis J.J.F. Effect of nitric oxide donors on extracellular ATP, ADP, and AMP catabolism in rat hippocampal synaptosomes. Brain Res. Bull. 55:2001;469-473.
19. 1 receptor inhibition. Neuroscience. 112:2002;319-329.
20. MacGregor D.G., Graham D.I., Stone T.W. The attenuation of kainate-induced neurotoxicity by chlormethiazole and its enhancement by dizocilpine, muscimol, and adenosine receptor agonists. Exp. Neurol. 148:1997;110-123.
21. Marescau B., Deshmukh D.R., Kockx M., Possemiers I., Qureshi I.A., Wiechert P., De Deyn P.P. Guanidino compounds in serum, urine, liver, kidney and brain of man and some urolytic animals. Metabolism. 41:1992;526-532.
22. Matsumoto M., Kobayashi K., Kishikawa H., Mori A. Convulsive activity of methylguanidine in cat and rabbit. IRCS Med. Sci. 4:1976;65.
23. Mori A. Biochemistry and neurotoxicity of guanidino compounds: history and recent advances. Pavlov. J. Biol. Sci. 22:1987;85-94.
24. Mori A., Kohno M., Masumizu T., Noda Y., Packer L. Guanidino compounds generate reactive oxygen species. Biochem. Mol. Biol. Int. 40:1996;135-143.
25. Nagy A., Delgado Escueta A.V. Rapid preparation of synaptosomes from mammalian brain using non-toxic isosmotic gradient material (Percoll). J. Neurochem. 43:1984;1114-1123.
26. Nagy A., Walton N.Y., Treiman D.M. Reduced cortical ecto-ATPase activity in rat brains during prolonged status epilepticus induced by sequential administration of lithium and pilocarpine. Mol. Chem. Neuropathol. 31:1997;135-147.
27. Ratnakumari L., Qureshi I.A., Butterworth R.F., Marescau B., De Deyn P.P. Arginine-related guanidine compounds and nitric oxide synthase in the brain of ornithine transcarbamylase deficient spf mutant mouse: effect of metabolic arginine deficiency. Neurosci. Lett. 215:1996;153-156.
28. Rocha J.B.T., Battastini A.M.O., Sarkis J.J.F., Dias R.D. Effect of chronic treatment with high doses of chlorpromazine on ATP and ADP hydrolysis by synaptosomal fractions from rat caudate nucleus. Braz. J. Med. Biol. Res. 23:1990;969-973.
29. Schetinger M.R.C., Bonan C.D., Schierholt R.C., Webber A., Arteni N., Emanuelli T., Dias R.D., Sarkis J.J.F., Netto C.A. Nucleotide hydrolysis in rats submitted to global cerebral ischemia: a possible link between preconditioning and adenosine production. J. Stroke Cerebr. Dis. 7:1998;281-286.
30. Schetinger M.R.C., Porto N.M., Moretto M.B., Morsch V.M., Rocha J.B.T., Vieira V., Stefanello F. New benzodiazepines alter acetylcholinesterase and ATPDase Activities. Neurochem. Res. 25:2000;949-955.
31. Schulte J.E., Sévigny J., Kaczmarek E., Siegel J.B., Imai M., Koziak K., Beaudoin A.R., Robson S.C. Structural elements and limited proteolysis of CD39 influence ATP diphosphohydrolase activity. Biochemistry. 38:1999;2248-2258.
32. Shiraga H., Hiramatsu M., Mori A. Convulsive activity of alpha-guanidinoglutaric acid and the possible involvement of 5-hydroxytryptamine in the alpha-guanidinoglutaric acid-induced seizure mechanism. J. Neurochem. 47:1986;1832-1836.
33. Siles E., Martinez-Lara E., Canuelo A., Sanchez M., Hernandez R., Lopez-Ramos J.C., Del Moral M.L., Esteban F.J., Blanco S., Pedrosa J.A., Rodrigo J., Peinado M.A. Age-related changes of the nitric oxide system in the rat brain. Brain Res. 956:2002;385-392.
34. +-ATPase activity from rat cerebral cortex by guanidine compounds accumulating in hyperargininemia. Brain Res. 838:1999;78-84.
35. Smith T.M., Kirley T.L. Cloning, sequencing, and expression of a human brain ecto-apyrase related to both the ecto-ATPase and CD39 ecto-apyrases. Biochim. Biophys. Acta. 1386:1998;65-78.
36. Smith T.M., Carl S.A.L., Kirley T.L. Mutagenesis of two conserved tryptophan residues of the E-type ATPases: inactivation and conversion of an ecto-apyrase to an ecto-ATPase. Biochemistry. 38:1999;5849-5857.
37. Vieira V.P., Rocha J.B.T., Stefanello F.M., Balz D., Morsch V.M., Schetinger M.R.C. Heparin and chondroitin sulfate inhibit adenine nucleotide hydrolysis in liver and kidney membrane enriched fractions. Int. J. Biochem. Cell Biol. 33:2001;1193-1201.
38. Wang T., Ou Y., Guidotti G. The transmembrane domains of ecto-apyrase (CD39) affect its enzymatic activity and quaternary structure. J. Biol. Chem. 273:1998;24814-24821.
39. Wierchert P., Marescau B., De Deyn P.P., Lowenthal A. Guanidino compounds in serum and brain of audiogenic sensitive rats during the preconvulsive running phase of cerebral seizures. Neuroscience. 13:1987;35-40.
40. Wiesinger H. Arginine metabolism and the synthesis of nitric oxide in the nervous system. Prog. Neurobiol. 64:2001;365-391.
41. Wyse A.T.S., Bavaresco C.S., Hagen M.E.K., Delwing D., Wannmacher C.M.D., Dutra-Filho C.S., Wajner M. In vitro stimulation of oxidative stress in cerebral cortex of rats by the guanidino compounds accumulating in hyperargininemia. Brain Res. 923:2001;50-57.
42. Yeguthin G.G., Burnstock G. Inhibitory effects of some purinergic agents on ecto-ATPase activity and pattern of stepwise ATP hydrolysis in rat liver plasma membranes. Biochim. Biophys. Acta. 1466:2000;234-244.
43. Zimmermann H. Ectonucleotidases: some recent developments and a note on nomenclature. Drug Develop. Res. 52:2001;44-56.
44. Zimmermann H., Braun N., Kegel B., Heine P. New insights into molecular structure and function of ectonucleotidases in the nervous system. Neurochem. Int. 3:1998;421-425.